Biotech & Medical

Biotech & Medical


Pharmaceutical Case Study

A pharmaceuticals distributor, recently acquired by private equity, was aware their systems were insufficient to provide visibility and process, but could not decide with confidence whether a Treasury Management System was a viable investment.

The main challenges were:

  • Cash balance reporting, cash flow forecasting, liquidity management and FX risk management were unachievable within desired time frames.
  • Their processes lacked a consistent sourcing and calculation process to achieve key actionable insights.
  • A Treasury management system investment size and implementation timeframe would not produce enough return on investment and they were unsure of alternative options.

Rochford’s solution included:

  • Rochford first isolated multiple workstreams for design and development within Excel that would have the highest value impact.
  • We ensured stakeholders stayed informed of development work and implemented updated processes wrapped in the system across three continents.
  • We continued to provide ongoing active management based on system outputs, from cash balance reporting through to M&A and Capex funding advice.

Outcomes:

  • We now have a weekly Treasury reporting process and have reduced time spent compiling monthly Board reports by 85%.
  • Rochford’s tools, processes and advice enable proactive cash management previously unavailable, eg funding M&A transactions through multiple revenue currencies while minimising trapped cash and required draws on revolver credit facilities.

BioTech Case Study

A biotechnology business, heavily focused on R&D
for years, was now experiencing rapid sales growth but was without a robust policy framework to protect against it’s also rapidly growing risk profile.

The main challenges were:

  • Increasing cash flow forecasts of a publicly listed entity meant that the size of potential losses from otherwise typical market moves was rapidly increasing.
  • The finance team and Board did not have direct experience developing an appropriate treasury policy.

Rochford’s solution included:

  • Rochford consulted with the CFO and presented a proposed hedging policy to the Board for approval.
  • We then worked with the finance team to execute an initial hedging strategy that ensured base compliance.
  • Ongoing proactive hedging decisions are now advised by Rochford with an appropriate product mix to ensure compliance, which we report on a monthly basis.

Outcomes:

  • Investors can encourage the Engineering, Sales and Finance team to focus on growing commercial opportunities with confidence their risk management program will scale alongside them.
  • Heightened revenue certainty from a smoothed earnings profile has reduced the business’ cost of capital and risk premium applied by investors, generating increased gains to enterprise value.

By clicking “Accept”, you are confirming that

  • You are a wholesale client within the meaning of section 761G of the Corporations Act 2001 or that you are acting for a wholesale client and
  • You acknowledge that the information contained on this website is intended for wholesale clients only and must not be distributed, directly or indirectly, to retail clients as defined under the act